NCT05613556已完成不适用
Monitoring Physiologic Parameters in Individuals With Diabetic Peripheral Neuropathy: a Prospective Study
Orpyx Medical Technologies Inc.1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2022年4月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- Frequency and location of high-pressure plantar areas
研究概览
简要总结
The primary aim of this study is to use the Orpyx® SI Sensory Insole System (Orpyx Medical Technologies Inc., Calgary AB, Canada) ("Orpyx" or "the Company") as an adjunct to diabetic peripheral neuropathy standard of care (SOC), and observe step count, pressure, temperature, and adherence data through remote patient monitoring (RPM). This will provide insights into patient engagement and the benefits of offering remote, preventative care.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 100 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Clinically diagnosed neuropathy and type 1 or 2 diabetes
- •Qualification as a "Moderate or High-Risk Participant," as defined by the International Working Group on the Diabetic Foot (IWGDF) Guidelines
- •Complete healing of any previous foot ulcers, as defined by complete re-epithelialization of healed ulcer which is confirmed by two medical exams that occur at least two to three weeks apart (V0 and V1)
- •Ability to walk independently (without use of wheelchair) for 30 steps
- •Aged >18 years
- •Ability to understand all the study and device requirements and have a life expectancy greater than the study duration
- •0.6 < [ABI] < 1.2, capillary refill time < 5 seconds (in the last 12 months)
- •Subject is willing and able to wear the Orpyx Sensory Insoles and provided diabetic footwear during all weight bearing activities (sitting, standing, walking, and wearing footwear)
- •Most recent HbA1c level of < 12.0% (in the last 12 months)
- •Subject or caregiver is able to see the bottom of their feet and inspect for redness, callus, and wounds as per standard of care
- •Subject is willing to wear the sensory insoles and carry the digital display device all day, but for a minimum of 4.5 hours a day
- •Subject is willing to charge the Orpyx SI Sensory Insoles overnight every night
排除标准
- •Active ulcer or presence of other open chronic wound (on foot or other body surface), regardless of etiology (e.g., vasculitis, neoplasms, or hematological disorders)
- •Past history of known non-neuropathic foot ulcer (i.e., arterial or venous insufficiency ulcer)
- •Presence of severe vascular disease (refer to acceptable ABI parameters in section 7.7.1)
- •Psychiatric illnesses or social situations that would limit compliance with the study
- •Serious underlying balance dysfunction, regardless of etiology
- •Significant cardiopulmonary or other systemic disease limiting the participant's ability to walk at least 30 steps or to stand for an amount of time equal to or greater than five (5) minutes
- •Current participation in another clinical investigation of a medical device or a drug; or participation in such a study within 30 days prior to this study enrolment
- •Current osteomyelitis or gangrene of the lower extremity
- •Uncorrected plantar Charcot neuroarthropathy
- •Bunion which would predispose ulcer formation (clinician discretion)
- •Extreme equinus
- •Hallux valgus
- •At the start of V1, the subject does not continue to meet the entrance criteria (inclusion and exclusion)
- •Hallux rigidus / limitus
- •Any condition that would affect or limit the ability to properly fit both shoes with the device under study
- •Subject has a history of intercurrent illness or conditions that would compromise the safety of the subject or their ability to participate in this study
- •Subject is in a site of care that is not conducive to ambulation or qualify for remote patient care (skilled nursing facility, acute care facility)
- •Amputations on the foot which require additive insole modifications (including but not limited to transmetatarsal, toe or ray amputations which create the need for a toe filler, or which prevent the subject from wearing the prescribed footwear)
结局指标
主要结局
Frequency and location of high-pressure plantar areas
时间窗: 3 months
frequency and location of high-pressure plantar areas
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Insole Sensor to Determine Optimal Limb Loading in the Rehabilitation of Ankle FracturesAnkle FractureNCT02334618University of Utah38
已完成
不适用
Insole Sensor to Determine Optimal Limb LoadingLower Extremity FracturesNCT02170493University of Utah19
招募中
不适用
Somatic Dysfunction in Patients With Acute Cerebrovascular DiseaseStroke, AcuteReproducibility of ResultsOsteopathic ManipulationHealth-Related Quality-of-LifeTIANCT06605014University of California, Davis120
已完成
2 期
Evaluation of a Diagnostic Feature in a Cardiac Resynchronization Therapy (CRT) DeviceCongestive Heart FailureNCT00957541ELA Medical, Inc.520
招募中
不适用
Recording of Physiological Data Via an Optical Sensor At the Fingertip Alongside with Double Auscultatory and Pulse Oximetry to Evaluate the Effectiveness of an Optical Blood Pressure Monitoring (OBPM)HypertensionNCT06368206Aktiia SA85